Temozolomid in der Behandlung maligner Gliome

Publication

Temozolomid in der Behandlung maligner Gliome

Journal Paper/Review - Jan 1, 2003

Hundsberger Thomas, Koch Dorothee, Klimpe Sven, Schlegel Uwe

Units

Neurologie, Medizinische Onkologie und Hämatologie

Citation

Hundsberger T, Koch D, Klimpe S, Schlegel U. Temozolomid in der Behandlung maligner Gliome. Aktuelle Neurologie 2003; 30:184-187.

Type

Journal Paper/Review (Deutsch)

Journal

Aktuelle Neurologie 2003; 30

Publication Date

Jan 1, 2003

Pages

184-187

Brief description/objective

Temozolomide is an orally administered, alkylating agent with approval for recurrent and progressive malignant gliomas. Here we review the pharmacological properties of temozolomide, its possible side effects and current indications for the treatment of malignant gliomas. Some current treatment trials on temozolomide are discussed, which may have an impact on its role in future Neuro-Oncology.